Share This Post
Security is often the first objection raised when Generative Ai shows up in regulated environments. The medical device case highlights a pragmatic response: retain the chatbot pattern, but upgrade the underlying platform to meet enterprise security expectations. For fractional technology leaders, this is less about chasing the latest model and more about hardening the delivery vehicle.
In the case study, the team moved to a team license with SOC 2 Type 2 compliance and robust encryption of data at rest using AES 256 and in transit using TLS 1.2. This step alone addressed a significant portion of the initial data security concerns, particularly around unauthorized access and transit exposure. However, configuration still mattered: they explicitly disabled use of customer and regulatory data for future model training, a critical safeguard in any regulated context.
This two layer approach, platform assurance plus configuration discipline, offers a pattern that fractional CIOs and CTOs can reuse across clients. The conversation with stakeholders becomes concrete: which certifications does the platform hold, how is data encrypted, and what controls exist to prevent data from leaking into shared training pools. Instead of abstract reassurances, leaders present a defined control set that maps directly to existing security frameworks.
When fractional technology leaders frame Generative Ai as an extension of current security practices, resistance tends to soften. The same rigor applied to SaaS procurement, cloud hosting, and vendor risk management is applied to Generative Ai platforms. The message is consistent: security is a prerequisite, not an afterthought, and it can be systematically addressed.
Download the full analyst brief to review the security posture and configuration decisions that enabled Generative Ai adoption in a regulated medical device environment.
